Recruit

We are excited to announce that the UCLA Immunogenetics Fellowship Training Program is now open for recruitment.

The UCLA Immunogenetics Center Director Trainee Program is an American Society for Histocompatibility and Immunogenetics (ASHI) accredited HLA laboratory director training program. This fellowship provides 2 years of formal training in Histocompatibility and Immunogenetics with the principal goal of providing trainees with the necessary knowledge, experience and skills to competently fulfill the responsibilities of a histocompatibility director. The goals of the fellowship program are to provide: 1) advanced training in Histocompatibility and Immunogenetics using state of the art diagnostic techniques; 2) training in clinical consultation and understanding of the clinical aspects of the patient populations served by the laboratory; 3) training in principles of laboratory management and 4) trainees with the knowledge and experience to sit for the American Board of Histocompatibility and Immunogenetics exam (ABHI) and direct HLA levorotary.

The fellowship is one of the most prestigious director-training programs offered by the UCLA Immunogenetics Center, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA. UIC has a track-record of excellent mentorship and success of the trainee. Under the direct guidance of the ASHI qualified directors clinical laboratory directors, the fellow will learn a full range of techniques including flow cytometry, solid phase HLA and non-HLA antibody testing, crossmatching, immune phenotyping and antigen specific responses, and molecular HLA typing using next generation sequencing technology. In addition, the fellow will become proficient at integrating specialized testing into diagnostic decision-making and performing clinical case reviews. Research opportunities in basic and translational clinical studies in Histocompatibility and Immunogenetics are available in collaboration with the laboratory directors. Completion of this post-doctoral fellowship training program will provide the trainee with two years of education and experience, with partial fulfillment of the requirements needed to be a qualified histocompatibility director under CLIA/CMS, United Network of Organ Sharing (UNOS) and ASHI standards.

ELIGIBILITY
The director trainee must have earned an MD or a PhD in Immunology, genetics, or in a related biological science from an accredited institution. In addition, the applicant should have at least 2 years of full-time post-doctoral laboratory training or experience in Immunology, Histocompatibility, or Immunogenetics; a residency in clinical and/or anatomic pathology or other related medical specialty; or have at least 2 years full-time post-doctoral training in directing or supervising high complexity testing in human Histocompatibility and Immunogenetics in an ASHI-accredited or approved laboratory. Reference letters documenting the level of clinical involvement are required.
RECRUITMENT PERIOD
Open July 1st, 2022 through Friday, Dec 15 at 11:59pm (Pacific Time)

Candidate interviews will be arranged during the months of January to March. Selection of the new fellow will be decided by the end of March.

If interested, please apply through the website below (Job #07670, David Geffen School of Medicine - PATHOLOGY & LABORATORY MEDICINE)

https://recruit.apo.ucla.edu/JPF07670

TO BE CONSIDERED FOR AN INTERVIEW
You must have a completed application on file that is composed of the items listed below:

1) Letter of intent summarizing your education, training and experience that are relevant to this training program
2) The candidate’s CV
3) Names and contact information for at least three references

Information For All Foreign Graduates
Please note we cannot support Research visas in the clinical laboratory specialties.

LEARN MORE
More information about this recruitment: http://pathology.ucla.edu/immunogeneticsuic

As a condition of employment, you will be required to comply with the University of California Policy on Vaccination Programs – With Updated Interim Amendments. All Covered Individuals under the policy must provide proof of receiving the COVID-19 Vaccine Primary Series or, if applicable, submit a request for Exception (based on Medical Exemption, Disability, Religious Objection, and/or Deferral based on pregnancy or recent COVID-19 diagnosis and/or treatment) no later than the applicable deadline. All Covered Individuals must also provide proof of receiving the most recent CDC-recommended COVID-19 booster or properly decline such booster no later than the applicable deadline. New University of California employees should refer to Exhibit 2, Section II.C. of the SARS-CoV-2 (COVID-19) Vaccination Program Attachment for applicable deadlines. All Covered Individuals must also provide proof of being Up-To-Date on seasonal influenza vaccination or properly decline such vaccination no later than the applicable deadline. Please refer to the Seasonal Influenza Vaccination Program Attachment. (Capitalized terms in this paragraph are defined in the policy.) Federal, state, or local public health directives may impose additional requirements.

The University of California is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age or protected veteran status. For the complete University of California nondiscrimination and affirmative action policy, see: UC Nondiscrimination & Affirmative Action Policy.